PRTC

Quote

Short

News

Articles

Message Board

PureTech names Robert Lyne as CEO

December 18, 2025 05:18:16 am

Source: SeekingAlpha

2025-12-18 05:18:16 ET

More on PureTech

Read the full article on Seeking Alpha

For further details see:

PureTech names Robert Lyne as CEO

PureTech Health plc

NASDAQ: PRTC

PRTC Trading

-3.98% G/L:

$16.65 Last:

5,385 Volume:

$17 Open:

mwn-alerts Ad 300

PRTC Latest News

February 19, 2026 12:36:00 pm

PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

January 06, 2026 07:00:00 am

PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025 02:00:00 am

PureTech Appoints Robert Lyne as Chief Executive Officer

December 08, 2025 02:00:00 am

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

PRTC Stock Data

Market Cap $420,648,153

Float 22,549,121

Insiders Ownership 10.3%

Institutions 2

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.puretechhealth.com

Country US

City Boston

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App